Skip to main content

Table 2 The relationship between KCNMA1 expression and clinicopathological feature of 75 GC patients

From: KCNMA1 cooperating with PTK2 is a novel tumor suppressor in gastric cancer and is associated with disease outcome

Clinicopatholocical variables

Number of each group

KCNMA1 expression

P value

High

Low

Age(years)

  < 60

27

13

14

0.878

  ≥ 60

48

24

24

 

Sex

 Male

62

30

32

0.720

 Female

13

7

6

 

Tumor size

  ≤ 5 cm

42

26

16

0.014

  > 5 cm

33

11

22

 

Tumor site

 Cardia

26

12

14

0.922

 Non-cardia

47

24

23

 

Histological type

 Diffuse

41

21

20

0.721

 Intestinal

34

16

18

 

Depth of invasion

 T1 + T2

15

4

11

0.179

 T3 + T4

60

20

35

 

Lymph nodedistant metastasis

 N0 + N1

20

11

9

0.554

 N2 + N3

55

26

29

 

Distant metastasis

 M0

62

30

32

0.720

 M1

13

7

6

 

TNM

 I + II

22

10

12

0.665

 III + IV

53

27

26

 
  1. The entries in bold showed the P value is less than 0.05